Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD280 (MRC2) Mouse anti-Human , PE, Clone: E1/183, BD Biosciences™

Catalog No. BDB566817 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB566817 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. BDB566817 Supplier BD Biosciences Supplier No. 566817
Only null left
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

CD280 (MRC2) Monoclonal antibody specifically detects CD280 (MRC2) in Human samples. It is validated for Flow Cytometry
TRUSTED_SUSTAINABILITY

Specifications

Antigen CD280 (MRC2)
Applications Flow Cytometry
Classification Monoclonal
Clone E1/183
Conjugate PE
Formulation Aqueous buffered solution containing ≤0.09% sodium azide.
Gene Alias MRC2; CLEC13E; endocytic receptor 180; ENDO180; UPARAP
Host Species Mouse
Immunogen AG1523 Human Fibroblasts
Quantity 0.1 mg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography. The antibody was conjugated with R-PE under optimum conditions, and unconjugated antibody and free PE were removed.
Isotype IgG1 κ
Show More Show Less
WARNING: Reproductive Harm - www.P65Warnings.ca.gov
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.